Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -33.80%7.15M | 20.62%22.22M | 178.35%13.76M | 15.78%3.87M | -168.63%-6.2M | 879.15%10.8M | 715.94%18.42M | -57.19%4.94M | 67.59%3.34M | 180.35%9.04M |
Net income from continuing operations | 63.82%-1.91M | -138.28%-12.45M | -130.68%-827K | -108.57%-447K | -157.03%-5.91M | -136.96%-5.27M | -34.09%32.53M | -84.13%2.7M | -59.06%5.22M | 12.20%10.36M |
Depreciation and amortization | 11.33%1.84M | 22.41%7.41M | 17.47%1.93M | 20.14%1.91M | 30.77%1.92M | 22.03%1.65M | 76.71%6.05M | 34.56%1.64M | 88.49%1.59M | 103.18%1.47M |
Deferred tax | -70.00%-544K | -92.90%-4.08M | 73.75%-555K | -9,608.57%-3.33M | 177.78%125K | -300.00%-320K | -548.47%-2.11M | ---2.11M | --35K | --45K |
Change In working capital | -49.48%7.39M | 271.73%31.11M | 380.71%13.11M | 273.84%5.69M | 14.35%-2.32M | 198.38%14.63M | 65.50%-18.12M | 138.84%2.73M | 73.23%-3.27M | 87.58%-2.7M |
-Change in receivables | -41.51%6.87M | -70.32%7.8M | 289.82%6.85M | -169.24%-5.65M | -130.47%-5.15M | 2,240.26%11.75M | 208.43%26.28M | 114.56%1.76M | 183.69%8.17M | 406.97%16.9M |
-Change in inventory | 64.81%6.87M | 312.09%31.99M | 33.03%8.55M | 311.53%9.03M | 195.41%10.25M | 164.09%4.17M | 65.52%-15.08M | 433.35%6.43M | 49.34%-4.27M | 38.09%-10.74M |
-Change in payables and accrued expense | -152.75%-5.33M | 101.95%544K | 85.38%-1.1M | 172.61%4.4M | 90.30%-644K | 72.40%-2.11M | -276.68%-27.84M | -206.14%-7.52M | -213.50%-6.05M | -516.31%-6.64M |
-Change in other current assets | -226.01%-1.03M | -529.26%-9.23M | -158.04%-1.2M | -85.96%-2.08M | -203.27%-6.77M | 563.07%815K | -419.86%-1.47M | 2,222.68%2.06M | -278.59%-1.12M | -336.59%-2.23M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -33.80%7.15M | 20.62%22.22M | 178.35%13.76M | 15.78%3.87M | -168.63%-6.2M | 879.15%10.8M | 715.94%18.42M | -57.19%4.94M | 67.59%3.34M | 180.35%9.04M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 1,374.89%13.39M | 93.86%-6.9M | -15,114.06%-19.22M | 110.23%11.17M | -99.75%248K | 100.90%908K | -1,269.37%-112.25M | 100.69%128K | -5,581.32%-109.2M | 676.17%97.91M |
Net PPE purchase and sale | 14.22%-2.07M | -14.11%-9.57M | -113.42%-3.96M | 29.62%-1.22M | 23.49%-1.98M | -8.99%-2.41M | 8.35%-8.38M | 22.19%-1.86M | 9.89%-1.73M | 7.42%-2.58M |
Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net investment purchase and sale | 365.69%15.46M | 102.57%2.67M | -869.49%-15.26M | 111.52%12.39M | -97.79%2.23M | 103.36%3.32M | -706.04%-103.86M | --1.98M | ---107.46M | 552.33%100.5M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 1,374.89%13.39M | 93.86%-6.9M | -15,114.06%-19.22M | 110.23%11.17M | -99.75%248K | 100.90%908K | -1,269.37%-112.25M | 100.69%128K | -5,581.32%-109.2M | 676.17%97.91M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 57.81%-6.39M | -132.09%-36.91M | -392.88%-3.87M | -1,895.19%-5.22M | -9,722.48%-12.67M | -113.34%-15.14M | 1,123.82%115M | -86.10%1.32M | 46.97%291K | -2.38%-129K |
Net issuance payments of debt | 102.59%77K | 76.07%-3.62M | -328.06%-3.62M | --0 | --2.97M | 82.20%-2.97M | -197.88%-15.11M | -89.73%1.59M | --0 | --0 |
Net common stock issuance | 46.88%-6.47M | -125.67%-33.28M | 5.24%-253K | -1,769.01%-5.22M | -5,328.76%-15.63M | -109.41%-12.17M | 15,140.95%129.65M | 76.41%-267K | 6.10%313K | --299K |
Proceeds from stock option exercised by employees | ---- | -101.73%-8K | 98.37%-8K | --0 | ---- | ---- | 108.93%463K | 89.78%-491K | --0 | ---299K |
Net other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---22K | -2.38%-129K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 57.81%-6.39M | -132.09%-36.91M | -392.88%-3.87M | -1,895.19%-5.22M | -9,722.48%-12.67M | -113.34%-15.14M | 1,123.82%115M | -86.10%1.32M | 46.97%291K | -2.38%-129K |
Net cash flow | ||||||||||
Beginning cash position | -57.26%16.17M | 127.19%37.83M | -18.36%25.62M | -88.46%15.82M | 13.76%34.48M | 127.19%37.83M | 25.98%16.65M | 121.15%31.39M | 884.57%137.08M | 139.02%30.31M |
Current changes in cash | 512.17%14.15M | -201.89%-21.58M | -245.93%-9.33M | 109.29%9.81M | -117.44%-18.63M | -125.38%-3.43M | 512.46%21.18M | 157.53%6.39M | -39,343.12%-105.56M | 8,507.82%106.82M |
Effect of exchange rate changes | 45.05%132K | -3,950.00%-81K | -358.00%-129K | 97.73%-3K | 27.27%-40K | -32.59%91K | 91.67%-2K | 308.33%50K | ---132K | ---55K |
End cash Position | -11.69%30.45M | -57.26%16.17M | -57.26%16.17M | -18.36%25.62M | -88.46%15.82M | 13.76%34.48M | 127.19%37.83M | 127.19%37.83M | 121.15%31.39M | 884.57%137.08M |
Free cash flow | -39.43%5.08M | 26.06%12.66M | 217.36%9.8M | 64.68%2.65M | -226.74%-8.18M | 855.68%8.39M | 245.72%10.04M | -66.30%3.09M | 2,164.79%1.61M | 145.97%6.45M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |